Board declares third quarter dividend on common and preferred stock SAN ANTONIO, July 31, 2025 /PRNewswire/ -- Cullen/Frost Bankers, Inc. (NYSE:CFR) today reported ...

Q2 2025 Management View CEO Matthew P. Flake reported strong financial results for the second quarter, including revenue of ...

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGNAnnounced capped royalty purchase agreement with Sobi under which ...

City Office REIT, Inc. (NYSE: CIO) (the "Company," "City Office," "we" or "our") today announced its results for the quarter ...